Amanote Research

Amanote Research

    RegisterSign In

Visual Outcomes of Polypoidal Choroidal Vasculopathy Treated With Intravitreal Ranibizumab With or Without Photodynamic Therapy

Acta Ophthalmologica - United States
doi 10.1111/aos.13467
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineOphthalmology
Date

April 29, 2017

Authors
Colin S. TanWei Kiong NgoLouis W. Lim
Publisher

Wiley


Related search

Photodynamic Therapy With Verteporfin for Polypoidal Choroidal Vasculopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2008English

Choroidal Morphology and Short-Term Outcomes of Combination Photodynamic Therapy in Polypoidal Choroidal Vasculopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2018English

Efficacy and Safety of Ranibizumab Monotherapy Versus Ranibizumab in Combination With Verteporfin Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy: 12-Month Outcomes in the Japanese Cohort of EVEREST II Study

Clinical Ophthalmology
Ophthalmology
2018English

Polypoidal Choroidal Vasculopathy

Ophthalmology
Ophthalmology
2018English

Polypoidal Choroidal Vasculopathy

Klinika Oczna
MedicineOphthalmology
2019English

Polypoidal Choroidal Vasculopathy

Archives of Ophthalmology
2003English

Polypoidal Choroidal Vasculopathy

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2007English

Polypoidal Choroidal Vasculopathy

International Journal of Retina
2018English

Choroidal Excavation With Polypoidal Choroidal Vasculopathy: A Case Report

Clinical Ophthalmology
Ophthalmology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy